Session Details

U035 Melasma in Skin of Colour: 2025 Update

Sat, Mar 8, 7:30 AM - 8:30 AM
W308A
1 CME Available Focus Session
View Map

DESCRIPTION

Open admission to eligible categories, no tuition or ticket

Melasma is a constant challenge in patients of skin of color. The session aims to diagnose, investigate and formulate a successful management strategy for these patients. Emphasis on newer topical actives for the treatment of pigmentation in skin of color, the use of chemical peels and microneedling and laser and energy based devices for this challenging skin condition will also be covered. Physician awareness will be highlighted on current treatments available for this difficult medical and aesthetic condition and clear treatment strategies will be outlined.

LEARNING OBJECTIVES

1.

Assess, diagnose and manage melasma in skin of color.

2.

Perform appropriate investigations for facial melanosis differential diagnoses.

3.

Formulate a treatment plan for effective management of these patients.

SCHEDULE

12:30 PM

MELASMA IN SKIN OF COLOUR - INTRODUCTION

Mukta Bhardwaj Sachdev, MD, IFAAD

12:33 PM

MELASMA - ETIOLOGY & DIAGNOSIS - NEW THINKING

Kavita Mariwalla, MD, FAAD

12:46 PM

MELASMA - MEDICAL MANAGEMENT- UPDATE

Mukta Bhardwaj Sachdev, MD, IFAAD

1:00 PM

MELASMA - PROCEDURAL MANAGEMENT- NEW TRENDS

Andrew F. Alexis, MD, MPH, FAAD

1:13 PM

MELASMA - CONCLUSION & THE FUTURE

Mukta Bhardwaj Sachdev, MD, IFAAD

1:16 PM

Q AND A

SPEAKERS

Andrew F. Alexis, MD, MPH, FAAD

Andrew F. Alexis, MD, MPH, FAAD

Kavita Mariwalla, MD, FAAD

Kavita Mariwalla, MD, FAAD

Mukta Bhardwaj Sachdev, MD, IFAAD

Mukta Bhardwaj Sachdev, MD, IFAAD

SPEAKER DISCLOSURES

Andrew F. Alexis, MD, MPH, FAAD

AbbVie – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding); Aerolase – Other(Equipment); Allergan, Inc. – Advisory Board(Honoraria); Almirall – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Alphyn Biologics – Advisory Board(Honoraria); Alumis – Advisory Board(Fees); Amgen – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding); Apogee BioPharm – Advisory Board(Honoraria); Arcutis Biotherapeutics – Investigator(Grants/Research Funding); Arcutis, Inc. – Advisory Board(Honoraria); Astra Zeneca – Advisory Board(Honoraria); Bausch Health – Advisory Board(Honoraria); Beiersdorf, Inc. – Advisory Board(Honoraria); Boehringer Ingelheim – Consultant (1099 relationship)(Honoraria); Botanix Pharmaceuticals – Advisory Board(Honoraria); Bristol-Myers Squibb – Advisory Board(Fees), Speaker(Honoraria); Canfield Scientific, Inc. – Consultant (1099 relationship)(Fees); Castle Biosciences – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Dermavant Sciences – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Dermavant Sciences, Inc. – Advisory Board(Honoraria); Eli Lilly – Consultant(Fees); Eli Lilly and Company – Advisory Board(Honoraria); Elsevier Inc. – Other(Other Financial Benefit); Foundation for Research & Education of Dermatology – Advisory Board(Honoraria); Galderma Laboratories, L.P. – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding); Genentech, Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); HairDays – Consultant (1099 relationship)(Fees); Incyte – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); janssen – Consultant (1099 relationship)(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria); Janssen Scientific Affairs, LLC – Consultant(Honoraria); Johnson and Johnson – Speaker(Honoraria); L'Oréal France – Advisory Board(Honoraria), Speaker(Honoraria); L'Oreal USA Inc. – Advisory Board(Honoraria), Consultant(Fees), Speaker(Honoraria); Leo Pharma Inc – Consultant(Fees); Leo Pharma Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Medscape – Other(Honoraria); Novartis – Advisory Board(Honoraria); OptiNose Inc. – Advisory Board(Honoraria); Oruka Therapeutics – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Pfizer Inc. – Advisory Board(Fees), Advisory Board(Honoraria), Speaker(Honoraria); RBC Consultants – Advisory Board(Honoraria); Regeneron – Advisory Board(Honoraria); Sanofi Genzyme – Advisory Board(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria), Speaker(Honoraria), Speaker/Faculty Education(Honoraria); Sanova Works – Speaker(Honoraria); Springer Science & Business Media – Other(Other Financial Benefit); Swiss American – Advisory Board(Honoraria); Symrise – Consultant (1099 relationship)(Fees); UCB – Advisory Board(Fees); UpToDate, Inc. – Other(Other Financial Benefit); VeraDermics Inc. – Advisory Board(Honoraria); VisualDx – Advisory Board(Honoraria); Wiley-Blackwell – Other(Other Financial Benefit);

Kavita Mariwalla, MD, FAAD

AbbVie – Investigator(Grants/Research Funding); BelleTorus Corporation – Stockholder(Stock Options); Boards University – Founder(Honoraria); Galderma USA – Advisory Board(Fees); L'Oreal USA Inc. – Consultant(Fees); Merz Aesthetics – Investigator(Grants/Research Funding); Neutrogena Corporation – Other(Honoraria); Skinfix, Inc. – Consultant(Fees); Unilever – Other(Honoraria);

Mukta Bhardwaj Sachdev, MD, IFAAD

Allergan, Inc. – Speaker(Honoraria); Alma Lasers – Speaker(Honoraria); Johnson and Johnson Consumer Products Company – Investigator(Grants/Research Funding); L'Oréal Research and Innovation – Investigator(Grants/Research Funding); Scientis – Advisory Board(Honoraria);